Copper chelation in patients with hypertrophic cardiomyopathy.
Anna ReidChristopher MillerJohn Peter FarrantRahul PolturiDavid ClarkSimon RayGarth CooperMatthias SchmittPublished in: Open heart (2022)
-selective chelation with trientine in a controlled environment is safe and a potential future therapeutic target. A phase 2b trial is now underway.